Evidence map›Paper›PMID 32469683›Full record

ArticleJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners2020

Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata, Japan.

Satoru Mitsuboshi, Masaki Yoshino, Hiroki Hosokawa, Hirokazu Isobe, Kenichi Kobayashi

Open access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Satoru MitsuboshiDepartment of Pharmacy, Kaetsu Hospital, Niigata, Japan.ORCID 0000-0002-6244-1253
Masaki YoshinoDepartments of Pharmacy, Niigata Prefectural Cancer Center Hospital, Niigata, Japan.
Hiroki HosokawaDepartment of Pharmacy, Agano City Hospital, Niigata, Japan.
Hirokazu IsobeDivision of Pharmacy, Niigata University Medical and Dental Hospital, Niigata, Japan.
Kenichi KobayashiDepartment of Pharmacy, Nagaoka Red Cross Hospital, Niigata, Japan.
Kaetsu University · JPNagaoka Red Cross Hospital · JPNiigata Cancer Center Hospital · JPNiigata City General Hospital · JPNiigata University Medical and Dental Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsCoronavirus InfectionsPandemicsPersonal Protective EquipmentPneumonia, ViralBetacoronavirusCOVID-19HumansJapanSARS-CoV-2Surveys and QuestionnairesAntineoplastic Agents

Identifiers

PMID32469683
OpenAlexW3029297778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.